Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Half-life About 159 to 195 hours (~7 to 8 days), which is why it is dosed weekly
Projected approval path: If Phase III trials confirm safety and effectiveness, Cagrilintide will likely be submitted for regulatory approval as a prescription obesity treatment in the next few years
Z79.84 for oral agents
Form & Stability Lyophilized powder for research purposes Store refrigerated (28 C) and protect from light Reconstitute under sterile conditions before use Disclaimer This compound is intended for laboratory and scientific research only
& Kim, M
US$ 22.38
US$ 24.36
US$ 20.78
